An overview of current and emerging devices for percutaneous left atrial appendage closure.

Authors :: Chow DHF
Wong YH
Park JW
Lam YY
De Potter T
Rodés-Cabau J
Asmarats L
Sandri M
Sideris E
McCaw T
Lee RJ
Sievert H
Søndergaard L
De Backer O
Source :: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2019 May; Vol. 29 (4), pp. 228-236. Date of Electronic Publication: 2018 Aug 30.
Publication Year :: 2019
Abstract: Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)

Subjects :: Animals
Atrial Fibrillation complications
Atrial Fibrillation diagnosis
Atrial Fibrillation physiopathology
Cardiac Catheterization adverse effects
Equipment Design
Humans
Risk Factors
Stroke diagnosis
Stroke etiology
Stroke physiopathology
Treatment Outcome
Atrial Appendage physiopathology
Atrial Fibrillation therapy
Cardiac Catheterization instrumentation
Stroke prevention & control

Full Text Access

Tools